Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$96,431
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Durso Jerome Benedict President and CEO Purchase +30,700 $1.62 $50K 93,200
2026-08-13 Durso Jerome Benedict President and CEO Purchase +15,000 $2.95 $44K 62,500
2026-04-01 Durso Jerome Benedict President and CEO Purchase +15,000 $3.14 $47K 47,500
2026-03-06 Durso Jerome Benedict President and CEO Purchase +20,000 $3.54 $71K 32,500
2025-12-22 Durso Jerome Benedict Director Purchase +12,500 $4.13 $52K 12,500
2025-12-01 Durso Jerome Benedict CEO-elect Grant or award · Stock Options (option to buy) +1,824,400 1,824,400
2025-12-01 Durso Jerome Benedict CEO-elect Grant or award · Restricted Stock Units +633,700 633,700
2025-09-25 Durso Jerome Benedict Director Grant or award · Stock Options (option to buy) +48,800 48,800
2025-02-24 Durso Jerome Benedict Director Grant or award · Stock Options (option to buy) +69,800 69,800

Page 1 of 1 · 9 trades